---
title: "Bristol-Myers Squibb (BMY) Gets a Hold from Erste Group"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281576159.md"
description: "Erste Group analyst has maintained a Hold rating on Bristol-Myers Squibb (BMY), with shares closing at $61.73. The overall analyst consensus suggests a Moderate Buy rating with an average price target of $62.67, indicating a potential upside of 1.52%. Additionally, Wells Fargo also assigned a Hold rating with a price target of $60.00."
datetime: "2026-04-02T20:05:56.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281576159.md)
  - [en](https://longbridge.com/en/news/281576159.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281576159.md)
---

# Bristol-Myers Squibb (BMY) Gets a Hold from Erste Group

Erste Group analyst maintained a Hold rating on Bristol-Myers Squibb yesterday. The company’s shares closed today at $61.73.

### End of Quarter Sale - 50% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Bristol-Myers Squibb with a $62.67 average price target, a 1.52% upside from current levels. In a report released today, Wells Fargo also assigned a Hold rating to the stock with a $60.00 price target.

### Related Stocks

- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [CELG.RT.US](https://longbridge.com/en/quote/CELG.RT.US.md)
- [BMY.US](https://longbridge.com/en/quote/BMY.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [RXL.US](https://longbridge.com/en/quote/RXL.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [PILL.US](https://longbridge.com/en/quote/PILL.US.md)

## Related News & Research

- [BMY Stock Rises as Bristol Myers Brings Anthropic's Claude AI to 30,000 Employees](https://longbridge.com/en/news/287076466.md)
- [Bristol-Myers Squibb-Anthropic AI Deal Targets Faster Drug Discovery](https://longbridge.com/en/news/287100303.md)
- [09:24 ETTigerlily Foundation Collaborates with Bristol Myers Squibb to Advance Clinical Trial Access and Equity](https://longbridge.com/en/news/286573689.md)
- [Tempus AI, Bristol Myers Squibb Expand AI-Driven Clinical Trial Efforts](https://longbridge.com/en/news/286453944.md)
- [<![CDATA[Bristol Myers Squibb, Hengrui Pharma Form $15.2 Billion Strategic Drug Development Collaboration]]>](https://longbridge.com/en/news/286124106.md)